07 November 2019
Visiongain has launched a new pharma report “Scanning Electron Microscopes Market Report 2020-2030” Prospects by Type (Scanning, Transmission), Application (Automobiles, Electronics & Semiconductors, Pharmaceuticals, Steel & other metals, Other applications) and Geography.
The global scanning electron microscopes market is projected to grow on account increasing demand of nanotechnology-based research, growing applications in semi-conductor, electronics & pharmaceutical industries among other contributing growth factors. The global market is projected to grow at a lucrative CAGR of ~10% over the forecast period 2020-2030 and anticipated to surpass USD 2 billion by 2020.
The scanning electron microscope (SEM) remains one of the most powerful and versatile tools used in research, development and production environments. The SEM is capable of imaging a wide range of sample types & sizes, often with nominal sample preparation, and is capable of generating multiple analytical signals, thus providing high-resolution information about a sample's composition, phase, electrical, optical, and other properties.
Key market drivers include increasing demand for nanotechnology-based research and the consequent growth in investments and funding from regional government bodies. Also, increasing applications in the semiconductors, electronic and pharmaceutical industries is expected to boost growth over the forecast period from 2020 to 2030.
Increasing global emphasis on R&D for applications such as neuroscience, material science, life science, nanotechnology, and semiconductor industry is anticipated to boost demand for adoption of advanced and automated microscopes such as analytical electron microscope, microscope scanning probe, and SEM. Such microscopes have image resolution as high as 0.1 nm, which is important for these manufacturing industries.
In terms of application, pharmaceutical dominated the global scanning electron microscope market in 2018 with over 35% of the global market share. Also, the growing burden of chronic diseases and other diseases in anticipated to boost further growth especially in the developing regions across the globe.
In the year 2018, Asia Pacific dominated the global scanning electron microscope market with over 35% of the global market share. The key factor that accounts for its significant share is rapid growth in applications such as semiconductors, pharmaceuticals, and nanotechnology among other applications.
North America is the second-largest market in terms of revenue owing to the presence of research and academic institutes and an increasing number of clinical studies across the United States. Research-based activities in the life sciences, biotechnology, and pharmaceutical industries are an important part of North American countries ' innovation system and this is anticipated to increase the regional demand for SEM over the forecast period.
Some of the major players operating in this industry are Angstrom Advanced Inc., Bruker Corporation, Carl Zeiss, Danish Micro Engineering (DME), FEI Company, Hirox Europe Ltd., Hitachi High Technologies Corporation, JEOL Ltd, Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding, Thermo Fisher Scientific., ADVANTEST, COXEM Co., Ltd., and GETec Microscopy GmbH among other prominent players.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.